Clinicians agree that evidence supports testing benefits for all
SAN FRANCISCO, Sept. 15, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, joined other clinical experts in releasing a new commentary in Journal of Clinical Oncology Precision Oncology, underscoring the importance of universal germline testing for all patients with cancer (solid tumors). The paper reports a meta-analysis of multiple clinical publications supporting universal testing, independent of age, stage, family history or type of cancer. It reports that for cancer types such as pancreatic and ovarian where universal genetic testing is already recommended, 13% and 20% of patients (respectively) have identifiable actionable heritable gene mutations,2. In comparison, the actionable inherited gene mutation rate for patients with other cancer types is similar: breast 11%, endometrial 13%, prostate 14%, kidney 13%, bladder 14%, testicular 13%, colorectal 13%, liver 14%, and stomach 14%.
Furthermore, it reports that between 5-13% of patients with cancer with heritable gene mutations are missed by current restrictive testing guidelines and are unable to benefit from associated precision treatment and clinical trial benefits. First, allowing all patients to receive germline testing, without restrictive guidelines, affords patients access to precision therapies, clinical trials and other risk reducing interventions that can improve outcomes, and even extend overall patient survival1. Second, genetic testing informs surveillance and risk reduction for future cancers in patients already affected by cancer. Third, cascade testing helps alert their family members of an increased risk for cancer, so they too can then take advantage of monitoring and risk reducing interventions. Consistent with the Cancer Moonshot 2.0and the President's Cancer Panel report 2022, the expert consensus concludes that current evidence supports the implementation of universal germline genetic testing for all patients with cancer (solid tumors).
"This consensus from nationally recognized, cancer genetics clinical experts reinforces the current guidelines that universal genetic testing be offered in all patients with ovarian and pancreatic cancer and either be offered or considered in all patients with colorectal," said Ed Esplin, MD, PhD, FACMG, FACP, clinical geneticist at Invitae. "More importantly, this is a call to all guidelines committees, insurer medical policy makers and the President's Cancer Moonshot Cabinetto make universal genetic testing available to potentially reduce mortality and improve the lives of all patients with cancer."
The collaborative commentary included experts from the Carolina Urologic Research Center, City of Hope, Dana-Farber Cancer Institute, Mayo Clinicand Invitae.
"The PROCLAIM studydemonstratesthe clinical utility of universal germline genetic testing in patients with prostate cancer. Current NCCN guidelines precludesome prostate cancer patients from receiving germline testing, thus depriving these patients of the potential to receive precision-based therapies and specificclinical trial eligibility, whileperpetuating healthcare disparities among historically underrepresented populations. The PROCLAIM data supports universal genetic testing for prostate cancer patients. We should expeditiously eliminate barriers to gene-based precision therapies to optimize patient outcomes and accelerate equitable access to care," said Neal Shore, MD, urologist and medical director, Carolina Urologic Research Center.
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.
Worldwide, there were an estimated 18.1 million new cases of cancer in 2018, with one in four men and one in five women developing the disease. In addition, there were 43.8 million persons living with cancer in 2018 who were diagnosed within the last five years.
"The INTERCEPT study has shown the prevalence and clinical utility of germline genetic testing is virtually the same across 14 cancer types, even those cancers not traditionally considered hereditary. This data supports universal genetic testing not only for colorectal cancer, but patients with all cancer types, to potentially improve their treatment and future cancer prevention for them and their family members," said Jewel Samadder, MD, enterprise co-leader precision/individualized cancer medicine, Mayo Clinic Comprehensive Cancer Center.
Restrictive guidelines can lead to disparities in cancer care. Offering germline genetic testing to all patients with cancer at diagnosis may help reduce inequities in cancer care by expanding access for all patients to precision therapy or clinical treatment trials.
"The prevalence of pathogenic variants in cancer susceptibility genes for which there are management guidelines is similar among patients with all types of solid tumors, therefore, it does not makes sense that current guidelines only recommend germline genetic testing for all patients with ovarian, pancreatic, and recently, colorectal cancers. This information has the potential to affect the treatment of these individuals' current cancers. In addition, it has the potential to allow for the prevention or early detection of future cancers in both these patients and their family members," said Heather Hampel, MS, CGC, professor, Department of Medical Oncology & Therapeutics Research, City of Hope.
About InvitaeInvitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time and lower prices. For more information, visit the company's website at invitae.com.
Safe Harbor StatementThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential benefits of universal genetic testing for all patients with cancer; and that restrictive guidelines can lead to disparities in cancer care. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the company's history of losses; the company's ability to compete; the company's failure to manage growth effectively; the company's need to scale its infrastructure in advance of demand for its tests and to increase demand for its tests; the company's ability to use rapidly changing genetic data to interpret test results accurately and consistently; security breaches, loss of data and other disruptions; laws and regulations applicable to the company's business; and the other risks set forth in the company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022. These forward-looking statements speak only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.
Contact:Renee Kelley[emailprotected](628) 213-3283
SOURCE Invitae Corporation
Read the original post:
Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer - PR Newswire
- Could Genetics Influence Cancer Risk From Red and Processed Meats? - Technology Networks - March 19th, 2024
- Genetics of environmental sensitivity and its association with variations in emotional problems, autistic traits, and ... - Nature.com - March 19th, 2024
- The Global Parkinson's Genetics Program and Psomagen Inc. Make Agreement with Goal to Transform Parkinson's ... - PR Newswire - March 19th, 2024
- SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear ... - Yahoo Finance - March 19th, 2024
- Mindfulness in your DNA? Capacity to be present is partly a function of genetics, study finds - PsyPost - March 19th, 2024
- Are your cattle genetics protected from the lab-grown meat industry? - Agweek - January 23rd, 2024
- AI Harnesses Tumor Genetics to Predict Treatment Response - University of California San Diego - January 23rd, 2024
- The Role of Genetics in Cancer Care Continues to Expand - OncLive - January 23rd, 2024
- Jeremy Allen White's Plush Pout Is Thanks to Genetics and This $20 Lip Salve - InStyle - January 23rd, 2024
- Seed Experimentation and Genetics Videos Mother Earth News - Mother Earth News - January 23rd, 2024
- Kansas professor highlights role of genetics in the sustainable cow herd - Canadian Cattlemen - January 23rd, 2024
- Raha Kapoor's blue eyes remind fans of her great-grandfather, Raj Kapoor; here's what genetics says - IndiaTimes - December 29th, 2023
- Cell perturbation and lasers illuminate the genetics of latent blood cell traits - Nature.com - December 29th, 2023
- BASIC GENETICS INFORMATION - Understanding Genetics - NCBI Bookshelf - December 20th, 2023
- What is Genetics? | AMNH - American Museum of Natural History - December 20th, 2023
- Genetics of host plants determine what microorganisms they attract, finds study - Phys.org - December 20th, 2023
- Perception of genomic newborn screening among peripartum mothers | European Journal of Human Genetics - Nature.com - December 20th, 2023
- Growing Cotton in Space: How breakthroughs in plant genetics could lead to more resilient crops on Earth - RFD-TV - December 20th, 2023
- Study sheds light on the ancestry and genetics of Coast Salish woolly dogs | News | Vancouver Island University ... - Vancouver Island University News - December 20th, 2023
- Early bird, night owl behavior influenced by genetics, lead to varying levels of productivity - The Campanile - December 20th, 2023
- Psoriasis: Whats the Genetic Link? - Healthline - December 27th, 2022
- Healthline: Medical information and health advice you can trust. - December 27th, 2022
- Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers - Scientific American - December 10th, 2022
- Genetics - breast cancer - October 29th, 2022
- JK Agri Genetics reports standalone net loss of Rs 15.77 crore in the September 2022 quarter - Business Standard - October 21st, 2022
- Age Vs. Genetics: Which Is More Important For How You Age? - Patch - October 13th, 2022
- Global Animal Genetics Market is estimated to garner a revenue of ~USD 10067 Million by the end of 2033; Growing Prevalence of Animal Infectious... - October 13th, 2022
- Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome - Nature.com - October 13th, 2022
- ASHG 2022 in Los Angeles brings together researchers from around the world to advance discoveries in genetics, genomics research - EurekAlert - October 13th, 2022
- Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 833% - Yahoo Finance - October 13th, 2022
- Global Biobank Meta-analysis Initiative making genome-wide association studies more diverse and representative - EurekAlert - October 13th, 2022
- Optimal for His Genetics Legendary Bodybuilder Ronnie Coleman Once Got His Genes Tested and Received Interesting Results - EssentiallySports - October 13th, 2022
- Breast Cancer Awareness | Surgeons see increase of genetic instances of disease - Meadville Tribune - October 13th, 2022
- About Bad Chest Genetics, and Whether You Can Fix Them - Healthline - October 4th, 2022
- Tissue-specific impacts of aging and genetics on gene expression patterns in humans - Nature.com - October 4th, 2022
- Genetics of human evolution wins 2022 Nobel Prize in physiology or medicine - Science News Magazine - October 4th, 2022
- Stroke genetics informs drug discovery and risk prediction across ancestries - Nature.com - October 4th, 2022
- Illumina aims to push genetics beyond the lab with $200 genome - The Spokesman Review - October 4th, 2022
- $2.6M DOE Grant Supports UMD-led Study on Genetics of Plant Growth - Maryland Today - October 4th, 2022
- Are Kinks Hereditary? What Science Says About the Genetics of Desire - Glamour - October 4th, 2022
- Study on rare genetic diseases among diverse demographics in India - The Hindu - October 4th, 2022
- Howard University's Office of Research Awarded $11.5 Million From Chan Zuckerberg Initiative To Advance Genomics And Genetics Research - The Dig - October 4th, 2022
- CENTOGENE Reaches 12,500 Patient Milestone in Worlds Largest Observational Study on Parkinsons Disease Genetics - Yahoo Finance - October 4th, 2022
- The real power ofimproved genetics - Farming Life - October 4th, 2022
- CIA Just Invested In Woolly Mammoth Resurrection Tech - The Intercept - October 4th, 2022
- Fighting the Monkeypox Virus: Genetics as a Predictor of Vaccinia Vaccine Effectiveness - Medical News Bulletin - October 4th, 2022
- Improved pea reference genome and pan-genome highlight genomic features and evolutionary characteristics - Nature.com - September 25th, 2022
- SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event - GlobeNewswire - September 25th, 2022
- TU Researchers connect genetic ancestry with prostate tumors - Tuskegee University - September 25th, 2022
- Large-scale and small-scale population genetic structure of the medically important gastropod species Bulinus truncatus (Gastropoda, Heterobranchia) -... - September 25th, 2022
- Purrsonalised health: The startups and VCs betting on pet genetics - Sifted - September 16th, 2022
- Uncovering the genetic basis of mental illness requires data and tools that aren't just based on white people - Down To Earth Magazine - September 16th, 2022
- Solving medical mysteries with genetics: The Penn Neurogenetics Therapy Center | Penn Today - Penn Today - September 16th, 2022
- CHOPs new bird-proofed skyscraper will focus on vaccine and genetics research - The Philadelphia Inquirer - September 16th, 2022
- Preimplantation Genetic Testing Market: Growing Demand for Genetically Testing and Rising Knowledge of Genetics to Drive the Market - BioSpace - September 16th, 2022
- People with ME invited to take part in major genetic study - The Independent - September 16th, 2022
- Can genetics breathe new life into giant river prawn production? - The Fish Site - September 16th, 2022
- Hybrid genetics is the future of UK beef, legendary US rancher says - FarmingUK - September 16th, 2022
- How geneticists can gain greater buy-in from the autistic community - Spectrum - September 16th, 2022
- Ancient Viking poop helped scientists map the genetics of a 5000-year-old parasite - Interesting Engineering - September 8th, 2022
- Project Uses OpenCDS, Chatbots to Broaden Genetic Testing's Reach - Healthcare Innovation - September 8th, 2022
- The power of genetics to unleash the potential of indoor farming - Vertical Farm Daily - September 8th, 2022
- Social Determinants and Genetics Work in Tandem to Drive Disparities in Breast Cancer Care - OncLive - September 8th, 2022
- Ticking away in the back of my mind: what does it mean to know the risk embedded in your DNA? - The Guardian - September 8th, 2022
- How are genetic technologies being applied to combat infectious diseases in aquaculture? - The Fish Site - September 8th, 2022
- CCMB zeroes in on major genetic causes of male infertility - The Hans India - September 8th, 2022
- In Brief This Week: Illumina, Interpace, Genetic Signatures, Guardant Health, More - GenomeWeb - September 8th, 2022
- Atossa Genetics (ATOS) Atossa Therapeutics, Inc. to Attend the 24th Annual H.C. Wainwright Global Inves - Benzinga - September 8th, 2022
- Genetics - National Institute of General Medical Sciences (NIGMS) - August 30th, 2022
- The genetics behind why some people get sicker with COVID-19 than others - ABC News - August 30th, 2022
- Ambry Genetics Publishes 43,000 Patient Study Showing Combined RNA and DNA Analysis Identifies Patients Who Are High-Risk for Cancer but Would Have... - August 30th, 2022
- Is COVID-19 Loss of Smell Genetic? What Research Shows - Healthline - August 30th, 2022
- Principal Component Analyses (PCA)-based findings in population genetic studies are highly biased and must be reevaluated | Scientific Reports -... - August 30th, 2022
- You're in control: Exercise outweighs genetics when it comes to longer life - Study Finds - August 30th, 2022
- An international team sets out to cure genetic heart diseases with one shot - Freethink - August 30th, 2022
- Olufunmilayo I. Olopade, MD: Cutting Into Breast Cancer Disparities With Genetic Testing - Everyday Health - August 30th, 2022
- Yale Study Suggests That Evolution Can Be Predicted - SciTechDaily - August 30th, 2022
- Could Genetics Be the Key to Never Getting the Coronavirus? - The Atlantic - July 27th, 2022
- Noonan appointed Kent Professor of Genetics and Professor of Neuroscience - Yale News - July 27th, 2022
- Happy 200th birthday, Gregor Mendel: 5 ways the father of modern genetics impacted your life today - Clemson News - July 27th, 2022